Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Targanta Therapeutics Corp.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Targanta Therapeutics Corp. since year 2005.
Table 2 shows the detailed insider transactions of Targanta Therapeutics Corp. since 2005.
The reporting company's ticker symbol is TARG. The reporting company's CIK number is 1398161.
The total value of stock buying since 2005 is $15,500,000.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2007-10-15||Venkatesan Jay (Director)||Buy||575,000||10.00||5,750,000|
|2007-10-15||Gordon Eric M (Director)||Buy||400,000||10.00||4,000,000|
|2007-10-15||Brookside Capital Partners Fund Lp (10% Owner)||Buy||575,000||10.00||5,750,000|
Insider trading activities including stock purchases, stock sales, and option exercises of TARG listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Targanta Therapeutics Corp. (symbol TARG, CIK number 1398161) see the Securities and Exchange Commission (SEC) website.